RTRui Tang

Rui Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rui Tang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Lin

    Department of Traditional Chinese Medicine Anorectal Department, The First Hospital of Putian City, Putian, China

    1 shared publication
  • Chaolin Lin

    Department of Traditional Chinese Medicine Anorectal Department, The First Hospital of Putian City, Putian, China

    1 shared publication
  • Haitao Wang

    The School of Clinical Medical Sciences Southwest Medical University Luzhou Sichuan China

    1 shared publication
  • Jian Yue

    School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China

    1 shared publication
  • Lanlan Cai

    Department of Traditional Chinese Medicine Anorectal Department, The First Hospital of Putian City, Putian, China

    1 shared publication
  • Li Li

    Department of Pathology, Luzhou Maternal and Child Health Hospital (Luzhou Second People’s Hospital), No. 99, Section 3, Longma Avenue, Longmatan District, Luzhou City, Sichuan Province 646000, China

    1 shared publication

Latest Publications

  • Open Access

    Type 2 diabetes and colorectal cancer: genetic causality explored via Mendelian randomization

    by Qiuhong Ke, Yongbing Huang, Libin Cheng, Chaolin Lin, Linhua Zhao, Wulong Huang, Zhisheng Chen, Yimin Xu, Yipiao Huang, Lanlan Cai, et al.

    Background The global burden of type 2 diabetes (T2D) and colorectal cancer (CRC) continues to rise. Observational studies have suggested a link between T2D and an elevated risk of CRC. However, these studies are often susceptible to confounding factors and reverse causation, leading to inconsistent findings. There is a specific gap in knowledge regarding the causal nature of the relationship between T2D and CRC, which this study aims to address using a more robust approach. To fill this gap, we employed Mendelian randomization (MR), a method that uses genetic variants as instrumental variables (IVs) to infer causality, providing clearer insight into the genetic links between T2D and CRC. Methods A bidirectional MR study was conducted to investigate the causal links between T2D and CRC. Genetic instruments for T2D were derived from two large genome-wide association studies (GWAS) with a total sample size of X individuals, and CRC genetic instruments were obtained from a GWAS with Y individuals. The MR analysis utilized the inverse-variance weighted (IVW) method as the primary analysis, alongside sensitivity analyses such as heterogeneity and pleiotropy analysis to account for potential pleiotropy and bias. Additionally, to enhance the robustness of the findings and minimize the influence of data from different GWAS sources, we performed a meta-analysis of the IVW results. Results The MR analysis and meta-analysis revealed that genetically predicted T2D is associated with an increased risk of CRC (Pooled ORIVW = 1.07, 95% CI 1.02–1.12, P = 0.003). However, the reverse analysis did not indicate a causal effect of genetically predicted CRC on T2D risk (Pooled ORIVW = 1.02, 95% CI 0.96–1.09, P = 0.469). Sensitivity analyses supported the robustness of these findings, indicating no evidence of heterogeneity or pleiotropic effects that could bias the results (all P > 0.05). Conclusion Our bidirectional MR study and meta-analysis provide evidence that T2D increases the risk of colorectal cancer. However, there is no evidence to support a reverse causal relationship. These findings highlight the importance of monitoring and managing T2D as part of CRC prevention strategies.


  • Open Access

    A Bioinformatics-Based Study on Methylation Alterations of the FBLN1 Gene in Hippocampal Tissue of Alzheimer’s Disease Model DKO and DTG Mice

    by Rui Tang, Yue Jian, Zhimin Hu, Li Li, Haitao Wang, Pengyu Miao, Zhihui Yang, Mingxi Tang

    Alzheimer’s disease (AD) is characterized by progressive cognitive decline and late-stage neurobehavioral issues marked by amyloid-beta plaques and Tau protein tangles. This study aims to investigate Fibulin-1(FBLN1) gene expression in the hippocampal tissue of Presenilin-1/Presenilin-2 conditional double-knockout (DKO) and double-transgenic (DTG) mice, using single-cell sequencing and experimental methods to verify abnormal methylation status and correlation with AD. Genomic DNA from DKO and DTG mice was used for genotyping. Reduced Representation Bisulfite Sequencing (RRBS) identified 10 genes with abnormal methylation changes, with protein–protein interaction (PPI) analysis highlighting five core genes, including FBLN1. Single-cell sequencing, RT-PCR, and Western blotting (WB) were used to analyze FBLN1 mRNA and protein levels in the hippocampal tissues of early-stage and mid-stage AD DKO, DTG, and CBAC57 mice. RRBS identified 10 genes with abnormal methylation, with PPI highlighting five core genes. Single-cell sequencing showed significant FBLN1 expression in AD groups. RT-PCR and WB indicated elevated FBLN1 mRNA and protein levels in mid-stage AD DKO and DTG mice compared to CBAC57 mice, with no differences in early-stage AD DKO and CBAC57 mice. RRBS revealed hypomethylation of the FBLN1 gene in mid-stage AD DKO mice. Elevated FBLN1 expression in AD models suggests an age-dependent neurodegenerative mechanism independent of amyloid-beta deposition. This study enhances our understanding of AD’s epigenetic mechanisms, which will aid targeted diagnosis, treatment, and prognosis.